CyndRx

Medical Equipment ManufacturingTennessee, United States2-10 Employees

CyndRx focuses on medical technology projects achievable within a 1-4 year timeline. Our goal is to develop innovative and disruptive technologies leveraging our in-house industry experiences and expertise to provide high-value return of investment.

Currently, CyndRx is fully dedicated to the development and commercialization of a market-differentiating vascular closure device platform, AbsorbaSeal™.

AbsorbaSeal™ , a Vascular Closure Device (VCD) platform, virtually eliminates the learning curve of VCDs with its very easy-to-use delivery and deployment, achieves safe and effective hemostasis with a bioabsorbable sealing mechanism that allows the target vessel to heal without chronic implants, while also focusing on economic value. The AbsorbaSeal™ VCD platform is scalable from small through large bore access (5F to 24F), offering the most innovative, clinically and economically valuable VCD platform to date.

Sign up for free to view info

Email Format Employee directory